Tarsus Pharmaceuticals Inc. (TARS): Price and Financial Metrics
TARS Price/Volume Stats
| Current price | $46.58 | 52-week high | $52.99 |
| Prev. close | $46.89 | 52-week low | $15.60 |
| Day low | $45.73 | Volume | 356,300 |
| Day high | $47.37 | Avg. volume | 729,563 |
| 50-day MA | $38.71 | Dividend yield | N/A |
| 200-day MA | $33.07 | Market Cap | 1.78B |
TARS Stock Price Chart Interactive Chart >
Tarsus Pharmaceuticals Inc. (TARS) Company Bio
Tarsus is a clinical-stage biopharmaceutical company headquartered in Irvine, California. Tarsus was founded in 2017 to bring innovative therapies to a range of diseases in need of better solutions, starting with Demodex blepharitis and eye care.
TARS Price Returns
| 1-mo | 22.58% |
| 3-mo | 82.45% |
| 6-mo | 33.05% |
| 1-year | 165.26% |
| 3-year | 84.48% |
| 5-year | N/A |
| YTD | 130.02% |
| 2023 | 38.13% |
| 2022 | -34.84% |
| 2021 | -45.56% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...